Company: ARVN
Filing Date: 2025-02-11
Form Type: 10-K
Source: 0001655759-25-000016
Chunk: 19

Company: ARVINAS, INC.
Filing Date: 2025-02-11
Form: 10-K
Item: Item 16
Chunk 19
---
076.9 Sale of marketable securities44.5 58.8 59.1 Purchase of property, equipment and leasehold improvements(1.8)(2.9)(6.8)Proceeds from disposal of property, equipment and leasehold improvements0.1 — — Net cash provided by investing activities34.7 203.5 242.8 Cash flows from financing activities:Repayments of long-term debt(0.4)— — Proceeds from issuance of common stock and pre-funded warrants— 387.2 — Payment of common stock offering costs— (17.0)— Proceeds from exercise of stock options and issuance of ESPP shares8.3 4.5 4.7 Net cash provided by financing activities7.9 374.7 4.7 Net (decrease) increase in cash, cash equivalents and restricted cash(216.7)230.4 (26.0)Cash, cash equivalents and restricted cash, beginning of the period317.2 86.8 112.8 Cash, cash equivalents and restricted cash, end of the period$100.5 $317.2 $86.8 Supplemental disclosure of cash flow information:Purchases of property, equipment and leasehold improvements unpaid at period end$0.9 $— $0.1 Cash paid for taxes$2.3 $11.1 $11.1 

See accompanying notes to the consolidated financial statements

F - 7

ARVINAS, INC. AND SUBSIDIARIES 

Notes to Consolidated Financial Statements 

1. Nature of Business and Basis of Presentation

Nature of BusinessArvinas, Inc. is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins. Arvinas, Inc. has four wholly owned subsidiaries; Arvinas Operations, Inc. formed in 2013, Arvinas Androgen Receptor, Inc. formed in 2015, Arvinas Estrogen Receptor, Inc. formed in 2016, and Arvinas Winchester, Inc. formed in 2018 (collectively, "Arvinas" or the "Company").Basis of PresentationThe Company's consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America ("